-
The Economic Times reported that Divi's Laboratories, Divi’s Laboratories Gland Celsus Bio Chemicals and Fidelity Trading Corporation have shown preliminary interest in taking over Orchid Pharma.
-
Other bidders keen to acquire the bulk cephalosporin drugmaker include financial investors Everstone, Piramal Capital, AION Capital, ART Capital and Finquest Group.
-
The news comes after the Chennai bench of the National Company Law Tribunal (NCLT) knocked back a proposal by Ingen Capital to take over Orchid Pharma after it failed to bring in the requisite money.










(All Rights Reserved)